Bon Natural Life Ltd., a leading bio-ingredient solutions provider, has announced a non-exclusive sales distribution agreement with Beijing Huahai Keyuan Technology Co., Ltd., a prominent wellness company in China. The agreement, valued at up to $16 million, spans 24 months and involves the marketing, sale, and distribution of Bon's natural prebiotic series products in the Chinese market. This collaboration is seen as a significant step forward in the gut health sector, featuring a cutting-edge "Prebiotic + Postbiotic" complex with the flagship active ingredient, super prebiotic stachyose. Bon anticipates this strategic partnership will accelerate its entry into China's rapidly growing gut health market, driving substantial growth opportunities for both companies.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.